The Resource The potential need for measurement standards to facilitate the research and development of biologic drugs : hearing before the Subcommittee on Technology and Innovation, Committee on Science and Technology, House of Representatives, One Hundred Eleventh Congress, first session, September 24, 2009

The potential need for measurement standards to facilitate the research and development of biologic drugs : hearing before the Subcommittee on Technology and Innovation, Committee on Science and Technology, House of Representatives, One Hundred Eleventh Congress, first session, September 24, 2009

Label
The potential need for measurement standards to facilitate the research and development of biologic drugs : hearing before the Subcommittee on Technology and Innovation, Committee on Science and Technology, House of Representatives, One Hundred Eleventh Congress, first session, September 24, 2009
Title
The potential need for measurement standards to facilitate the research and development of biologic drugs
Title remainder
hearing before the Subcommittee on Technology and Innovation, Committee on Science and Technology, House of Representatives, One Hundred Eleventh Congress, first session, September 24, 2009
Creator
Subject
Genre
Language
eng
Member of
Cataloging source
GPO
http://bibfra.me/vocab/lite/collectionName
HeinOnline U.S. Congressional Documents Library
Government publication
federal national government publication
Illustrations
illustrations
Index
no index present
LC call number
KF27
LC item number
.S39956 2009f ONLINE
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://bibfra.me/vocab/lite/organizationName
United States
http://library.link/vocab/subjectName
  • Biologicals
  • Drugs
  • United States
Label
The potential need for measurement standards to facilitate the research and development of biologic drugs : hearing before the Subcommittee on Technology and Innovation, Committee on Science and Technology, House of Representatives, One Hundred Eleventh Congress, first session, September 24, 2009
Instantiates
Publication
Note
  • Title from title screen (viewed on Mar. 17, 2010)
  • Paper version available for sale by the Supt. of Docs., U.S.G.P.O
  • "Serial no. 111-53."
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
black and white
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Q5E comparability of biotechnological/biological products subject to changes in their manufacturing process
  • Comparability of medicinal products containing biotechnology-derived proteins as active substance quality issues
  • FDA guidance concerning demonstration of comparability of human biological products, including therapeutic biotechnology-derived products
Control code
557601871
Dimensions
unknown
Extent
1 online resource (iv, 112 pages)
File format
one file format
Form of item
online
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations
http://library.link/vocab/ext/overdrive/overdriveId
552-070-40346-9
Specific material designation
remote
System control number
(OCoLC)557601871
Label
The potential need for measurement standards to facilitate the research and development of biologic drugs : hearing before the Subcommittee on Technology and Innovation, Committee on Science and Technology, House of Representatives, One Hundred Eleventh Congress, first session, September 24, 2009
Publication
Note
  • Title from title screen (viewed on Mar. 17, 2010)
  • Paper version available for sale by the Supt. of Docs., U.S.G.P.O
  • "Serial no. 111-53."
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
black and white
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Q5E comparability of biotechnological/biological products subject to changes in their manufacturing process
  • Comparability of medicinal products containing biotechnology-derived proteins as active substance quality issues
  • FDA guidance concerning demonstration of comparability of human biological products, including therapeutic biotechnology-derived products
Control code
557601871
Dimensions
unknown
Extent
1 online resource (iv, 112 pages)
File format
one file format
Form of item
online
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations
http://library.link/vocab/ext/overdrive/overdriveId
552-070-40346-9
Specific material designation
remote
System control number
(OCoLC)557601871

Library Locations

    • Pardee Legal Research CenterBorrow it
      5998 Alcalá Park, San Diego, CA, 92110-2492, US
      32.771471 -117.187496
Processing Feedback ...